Positional Candidate Gene Analysis of Lim Domain Homeobox Gene (Isl-1) on Chromosome 5q11-q13 in a French Morbidly Obese Population Suggests Indication for Association With Type 2 Diabetes

  1. Mouna Barat-Houari1,
  2. Karine Clément2,
  3. Vincent Vatin1,
  4. Christian Dina1,
  5. Geneviève Bonhomme2,
  6. Francis Vasseur1,
  7. Bernard Guy-Grand2 and
  8. Philippe Froguel13
  1. 1Institute of Biology, Centre National de la Recherche Scientifique (CNRS) 80-90, Lille, France
  2. 2Laboratory and Department of Medicine and Nutrition-EA3502, Paris, France
  3. 3Barts and the London Genome Center, Queen Mary’s School of Medicine, London, U.K.

    Abstract

    The Lim domain homeobox gene (Isl-1) is a positional candidate gene for obesity that maps on chromosome 5q11-q13, a locus linked to BMI and leptin levels in French Caucasians. Isl-1 might be involved in body weight regulation and glucose homeostasis via the activation of proglucagon gene expression, which encodes for glucagon and glucagon-like peptides. By mutation screening of 72 obese subjects, we identified three single-nucleotide polymorphisms (SNPs) in the Isl1 gene. The allele frequencies in the morbidly obese group did not differ from that of the control group. In the obese group, the −47G allele was associated with a decreased risk of type 2 diabetes (odds ratio 0.41, P = 0.019). The AG bearers displayed a higher maximal BMI than the AA bearers in the whole obese group (P = 0.026) as well as in the type 2 diabetic obese subgroup (P = 0.014). In obese families, this allele was not preferentially transmitted from heterozygous parents to their obese siblings, indicating that Isl-1 does not contribute to the linkage with obesity on 5cen-q. However, in French Caucasian morbidly obese subjects, the Isl1-47A→G SNP may modulate the risk for type 2 diabetes and may increase body weight in diabetic morbidly obese subjects.

    Footnotes

    • Address correspondence and reprint requests to Philippe Froguel, CNRS 8090, Institut Pasteur de Lille, 1 rue Calmette, 59000 Lille, France. E-mail: froguel{at}mail-good.pasteur-lille.fr. Alternative address for correspondence: Barts and the London Genome Center, Queen Mary’s School of Medicine, London, 156 Sciences Building Charterhouse Square, London EC1M-6BQ, U.K.

      Additional information can be found in an online appendix at http://diabetes.diabetesjournals.org.

      Received for publication 3 August 2001 and accepted in revised form 7 February 2002.

      GLP, glucagon-like peptide; GLP-R, GLP receptor; OR, odds ratio; SNP, single-nucleotide polymorphism; TDT, transmission disequilibrium test.

    « Previous | Next Article »Table of Contents